Scientist to Watch

» infectious disease, behavior and cancer

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Megan Carey: Cerebellum Prober

Megan Carey: Cerebellum Prober

By | August 1, 2012

Group Leader, Neuroscience Program, Champalimaud Center for the Unknown, Lisbon, Portugal; HHMI International Early Career Scientist; Age: 38

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

image: Seirian Sumner: Wasp Whisperer

Seirian Sumner: Wasp Whisperer

By | August 1, 2011

Research Fellow, Institute of Zoology, London. Age: 37

0 Comments

image: Harmit Malik: Viral Historian

Harmit Malik: Viral Historian

By | July 1, 2011

Member, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Age: 38

3 Comments

image: Ted Cohen: Travelling for TB

Ted Cohen: Travelling for TB

By | March 1, 2011

Assistant professor, Department of Epidemiology, Harvard School of Public Health. Age: 37

0 Comments

image: Jeremy Reiter: Hunting for Cilia

Jeremy Reiter: Hunting for Cilia

By | January 1, 2011

Assistant professor of biochemistry, University of California, San Francisco. Age: 39

3 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech